Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00672217 · ClinicalTrials.gov registry record · NA

Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
64
Enrollment target

NCT00672217 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00672217, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

The primary goal of the proposed study is to examine a cognitive behavioral intervention for insomnia (CBTI) in women after breast cancer treatment. Chronic Insomnia is a highly prevalent and distressing symptom in cancer patients. CBTI is considered the treatment of choice for chronic primary insomnia. Few studies have been conducted in cancer survivors to evaluate the effect of CBTI on sleep and clinically relevant outcomes.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBTI)
  • BEHAVIORAL Behavioral Placebo Treatment

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2008-07
Est. Completion 2013-05
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00672217

The ClinicalTrials.gov registry entry for NCT00672217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia (CBTI) is the first listed.

NCT00672217 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00672217 about?

NCT00672217 is a clinical study titled "Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment". The primary goal of the proposed study is to examine a cognitive behavioral intervention for insomnia (CBTI) in women after breast cancer treatment. Chronic Insomnia is a highly prevalent and distressing symptom in cancer patients. CBTI is considered the treatment of choice for chronic primary insom...

What is the current status of trial NCT00672217?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2008-07. Estimated completion is 2013-05.

What interventions are being tested in trial NCT00672217?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBTI) (BEHAVIORAL), Behavioral Placebo Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00672217?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.